BioDelivery Sciences signs deal with nonprofit group

01/26/2009 | Pharmaceutical Business Review Online

BioDelivery Sciences International has agreed to work with the nonprofit Drugs for Neglected Diseases initiative in testing the safety and efficacy of Bioral Amphotericin B, a treatment for leishmaniasis, Chagas' disease and other communicable diseases. Bioral Amphotericin B uses BDSI's patented Bioral drug delivery technology to allow the drug to be administered orally rather than intravenously.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR